Evidence map›Paper›PMID 41654811›Full record

ReviewJournal of nanobiotechnology2026

Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives.

Baozhu Zhang, Muhammad Sohaib Iqbal, Yibin Yan, Han Wang, Xuejin Wang, Yinghe Zhang, Bing Guo

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baozhu ZhangDepartment of Radiation Oncology, The People's Hospital of Baoan, Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen, China. always_cherish@sina.com.
Muhammad Sohaib IqbalSchool of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
Yibin YanSchool of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
Han WangSchool of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
Xuejin WangSchool of Science, Harbin Institute of Technology, Shenzhen, 518055, China.
Yinghe ZhangShenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, 518055, China.
Bing GuoSchool of Science, Harbin Institute of Technology, Shenzhen, 518055, China. guobing2020@hit.edu.cn.

Funding

Guangdong Basic and Applied Basic Research Foundation 2025A1515011922)High-quality Development Research Project of Public Hospitals under Bao'an District, Health Bureau of Bao'an District, Shenzhen BAGZL2024041Medical and Health Research Project of Bao'an District, Science and Technology Innovation Bureau of Bao'an District, Shenzhen BA202400754203X012202404240018Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application ZDSYS20220527171407017Special Foundation for General Basic Research Program of Shenzhen JCYJ20240813105122030)
6 · The paper itself

Abstract

Liver Cancer, one of the most lethal cancers in adults, is distinguished by its aggressive invasion, distinctive tumor microenvironment (TME) and resistance to standard treatments, posing challenges. The TME and fibrotic extracellular matrix (ECM) hampers effective drug distribution; hence, new developments in therapeutics have brought creative solutions to these problems. To temporarily breach these barriers and enable targeted treatment, various dynamic therapies using stimuli such as focused Ultrasound, light, chemical reactions, mechanical stress, microwave induction and magnetic fields have demonstrated great promise in inducing localized and spatiotemporal therapeutic effects. This comprehensive review highlights the therapeutic mechanisms, including both chemical and biological effects and elucidates the therapeutic promise of emerging nanomedicine across individual modalities such as sonodynamic therapy (SDT), photodynamic therapy (PDT) and chemodynamic therapy (CDT), supported by preclinical evidence. Thereafter, promising combinatorial dynamic strategies with superior therapeutic effects are outlined. Furthermore, emerging next-generation modalities, including piezodynamic therapy (PZDT), microwave dynamic therapy (MWDT) and magnetodynamic therapy (MDT), with their therapeutic perspectives are discussed in detail. Although these strategies employing emerging nanomedicines have shown remarkable therapeutic potential for clinical translation, controlling physical stimulation and ensuring nanoparticle biocompatibility remain challenging. Continued innovations in medicine and chemistry will be essential for transforming dynamic strategies into clinically viable strategies for liver oncology.

Indexed as

Liver NeoplasmsNanomedicineAnimalsAntineoplastic AgentsCombined Modality TherapyHumansNanoparticlesPhotochemotherapyTumor MicroenvironmentAntineoplastic AgentsCombinatorial dynamic therapiesDynamic therapiesFenton reactionsLiver cancerTumor microenvironment

Identifiers

PMID41654811
PMCPMC12977788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.